GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly development in how we handle type 2 diabetes . These new therapies help imitating the body’s inherent GLP-1 substance , which https://shaniajxwo539140.ziblogs.com/42253085/glp-1-a-major-breakthrough-in-glucose-care